Berkshire Hathaway Buys UnitedHealth and Reveals Mystery Stocks

Berkshire Hathaway's Q2 13F filing revealed significant portfolio adjustments, notably reducing its Apple stake by 69% for an estimated $99.6 billion gain and its Bank of America holding by 41% for a $12.1 billion gain. Concurrently, Berkshire initiated a new $2.1 billion position in UnitedHealth Group amidst the insurer's recent stock decline and regulatory scrutiny. The filing also unveiled previously hidden stakes in homebuilders D.R. Horton and Lennar, along with a new position in Nucor, signaling strategic plays in the housing and steel sectors.

Analysis

Berkshire Hathaway's second-quarter 13F filing reveals a significant strategic portfolio rebalancing, characterized by substantial profit-taking in long-held technology and financial positions and a redeployment of capital into cyclical and value-oriented sectors. The firm continued to trim its Apple stake, reducing it by 69% since September 2023 and realizing an estimated gain of $99.6 billion, while also cutting its Bank of America position by 41% for a $12.1 billion gain. Concurrently, Berkshire initiated a major new position in UnitedHealth Group, investing an estimated $2.1 billion. This move represents a classic contrarian bet, as it was made while UnitedHealth's shares had plunged 40% during the quarter due to rising medical costs, disappointing earnings, and ongoing investigations. The filing also unveiled previously confidential stakes in homebuilders D.R. Horton and Lennar, and steel producer Nucor, accumulated since the beginning of the year. The significant build-up in Lennar and the new position in Nucor signal a bullish thesis on the US housing and industrial materials sectors, with the latter benefiting from a dynamic market and trade tariffs.

Key Decisions for Investors

• Investors should assess Berkshire's $2.1 billion investment in UnitedHealth as a strong contrarian signal, weighing the potential long-term value against the significant near-term headwinds from rising costs and regulatory scrutiny that have depressed the stock.
• The newly disclosed, substantial positions in homebuilders D.R. Horton and Lennar, alongside steel producer Nucor, indicate a clear thematic bet on US housing and industrial activity, warranting a review of exposure to these cyclical sectors.
• The continued, large-scale selling of Apple and Bank of America represents significant profit-taking and may signal a strategic rotation; holders of these stocks should consider that a key long-term investor is actively reducing its position.
• Given the shift from mega-cap holdings toward value-oriented healthcare and cyclical industrial and housing names, it may be prudent to evaluate whether a similar portfolio rotation aligns with your own market outlook.